Immunomodulatory Therapies for Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Immunomodulatory Therapies for Renal Cell Carcinoma

Published:2018-08-28 Issue:6 Volume:25 Page:534-547
ISSN:0929-8665
Container-title:Protein & Peptide Letters
language:en
Short-container-title:PPL

Author:

Liu Min¹,Wu Huizi¹,Shangguan Dangang²,Jiang Yueping¹,Li Xiangping¹,Liu Shao¹,Zhou Boting¹,Yin Tao³,Gong Zhicheng¹

Affiliation:

1. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China

2. The Affiliated Tumor Hospital of Xiangya Medical School of Central South University, Changsha 410013, China

3. Xiangya Hospital, CeDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008ntral South University - Department of Pharmacy Changsha, China

Publisher

Bentham Science Publishers Ltd.

Subject

Biochemistry,General Medicine,Structural Biology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial;Journal of Oncology;2022-07-30

2. EZH2 is a potential prognostic predictor of glioma;Journal of Cellular and Molecular Medicine;2020-12-04

3. Suppressive effects of RASAL2 on renal cell carcinoma via SOX2/ERK/p38 MAPK pathway;Experimental and Therapeutic Medicine;2020-10-06

4. Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients;Cancer Cell International;2019-04-16

5. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome;Journal of Immunology Research;2018-09-06